Racial Disparities in Transcatheter and Surgical Aortic Valve Replacement

Background Transcatheter and surgical aortic valve replacement (TAVR, SAVR) is disproportionately distributed across racial and ethnicity groups.1, 2 Nationally, 87-91% of individuals undergoing AVR are White, despite making up approximately 60% of the US population.1-4 Jefferson’s AVR demographic data is consistent with national trends. Further studies have found that zip codes associated with lower socioeconomic status (SES) have lower rates of TAVR.5 Although this disparity is widely recognized, there lacks understanding of contributing factors and potential interventions. Project Aim: Investigate additional demographic data of Thomas Jefferson University Hospital (TJUH) patients undergoing TAVR to isolate targets for future intervention

Appropriateness of TAVR in the Chronic Liver Patient Undergoing Liver Transplant Evaluation

As the indications for Transcatheter Aortic Valve Replacement (TAVR) continue to expand, understanding appropriate patient selection is becoming an area of growing interest. The presence of Liver cirrhosis has been previously proven to increase perioperative morbidity and mortality in patients undergoing general surgical procedures. However, there is limited research articulating clinical outcomes in TAVR patients with known liver disease who are actively undergoing orthotopic liver transplant evaluation (OLT).https://jdc.jefferson.edu/cardiologyposters/1001/thumbnail.jp